China Resources Shuanghe announced that Henan Zhongshuai Pharmaceutical Technology Co., Ltd., a holding subsidiary of the company, recently received the “Drug Registration Certificate” for acetazolamide extended-release capsules issued by the State Drug Administration. The drug registration classification is Class 3 chemicals, with a specification of 0.5 g. The drug approval number is Sinopharm H20265455. This drug is used to prevent or ameliorate the symptoms of acute mountain sickness. It is the first such drug approved in China, and is deemed to have passed the consistency evaluation. As of the announcement date, the company's total R&D investment for this drug was 16.568 million yuan.

China Resources Shuanghe announced that Henan Zhongshuai Pharmaceutical Technology Co., Ltd., a holding subsidiary of the company, recently received the “Drug Registration Certificate” for acetazolamide extended-release capsules issued by the State Drug Administration. The drug registration classification is Class 3 chemicals, with a specification of 0.5 g. The drug approval number is Sinopharm H20265455. This drug is used to prevent or ameliorate the symptoms of acute mountain sickness. It is the first such drug approved in China, and is deemed to have passed the consistency evaluation. As of the announcement date, the company's total R&D investment for this drug was 16.568 million yuan.